October 10, 2015
Recommended Topic Related To:

Emend Injection

"The U.S. Food and Drug Administration today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.


Emend Injection


No information provided. Please refer to the WARNINGS AND PRECAUTIONS section.

Last reviewed on RxList: 8/27/2014
This monograph has been modified to include the generic and brand name in many instances.

Emend Injection - User Reviews

Emend Injection User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Emend Injection sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Get the latest treatment options.